• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BCL-6原癌基因控制生发中心的形成和2型辅助性T细胞炎症反应。

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.

作者信息

Ye B H, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti R S, Rothman P, Stall A M, Pandolfi P P, Dalla-Favera R

机构信息

Department of Pathology, Columbia University, New York, New York 10032, USA.

出版信息

Nat Genet. 1997 Jun;16(2):161-70. doi: 10.1038/ng0697-161.

DOI:10.1038/ng0697-161
PMID:9171827
Abstract

Structural alterations of the promoter region of the BCL-6 proto-oncogene represent the most frequent genetic alteration associated with non-Hodgkin lymphoma, a malignancy often deriving from germinal-centre B cells. The BCL-6 gene encodes a zinc-finger transcriptional repressor normally expressed in both B cells and CD4+ T cells within germinal centres, but its precise function is unknown. We show that mice deficient in BCL-6 displayed normal B-cell, T-cell and lymphoid-organ development but have a selective defect in T-cell-dependent antibody responses. This defect included a complete lack of affinity maturation and was due to the inability of follicular B cells to proliferate and form germinal centres. In addition, BCL-6-deficient mice developed an inflammatory response in multiple organs characterized by infiltrations of eosinophils and IgE-bearing B lymphocytes typical of a Th2-mediated hyperimmune response. Thus, BCL-6 functions as a transcriptional switch that controls germinal centre formation and may also modulate specific T-cell-mediated responses. Altered expression of BCL-6 in lymphoma represents a deregulation of the pathway normally leading to B cell proliferation and germinal centre formation.

摘要

BCL-6原癌基因启动子区域的结构改变是与非霍奇金淋巴瘤相关的最常见基因改变,非霍奇金淋巴瘤是一种通常起源于生发中心B细胞的恶性肿瘤。BCL-6基因编码一种锌指转录抑制因子,通常在生发中心的B细胞和CD4+T细胞中表达,但其确切功能尚不清楚。我们发现,缺乏BCL-6的小鼠B细胞、T细胞和淋巴器官发育正常,但在T细胞依赖性抗体反应中存在选择性缺陷。这种缺陷包括完全缺乏亲和力成熟,原因是滤泡B细胞无法增殖并形成生发中心。此外,缺乏BCL-6的小鼠在多个器官中出现炎症反应,其特征是嗜酸性粒细胞和携带IgE的B淋巴细胞浸润,这是Th2介导的超敏反应的典型表现。因此,BCL-6作为一种转录开关,控制生发中心的形成,也可能调节特定的T细胞介导的反应。淋巴瘤中BCL-6表达的改变代表了通常导致B细胞增殖和生发中心形成的途径的失调。

相似文献

1
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.BCL-6原癌基因控制生发中心的形成和2型辅助性T细胞炎症反应。
Nat Genet. 1997 Jun;16(2):161-70. doi: 10.1038/ng0697-161.
2
The proto-oncogene BCL-6 in normal and malignant B cell development.原癌基因BCL-6在正常和恶性B细胞发育中的作用
Hematol Oncol. 2002 Dec;20(4):155-66. doi: 10.1002/hon.689.
3
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.BCL6原癌基因抑制生发中心B细胞中的p53表达。
Nature. 2004 Dec 2;432(7017):635-9. doi: 10.1038/nature03147.
4
BCL-6 regulates chemokine gene transcription in macrophages.BCL-6调节巨噬细胞中趋化因子基因的转录。
Nat Immunol. 2000 Sep;1(3):214-20. doi: 10.1038/79749.
5
PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.PU.1蛋白表达与生发中心B细胞基因(包括BCL-6、CD10、CD20和CD22)的蛋白表达呈正线性关联:在BCL-6启动子中鉴定PU.1假定结合位点。
J Pathol. 2005 Jul;206(3):312-9. doi: 10.1002/path.1777.
6
Induction of BCL-6 gene expression by interferon-gamma and identification of an IRE in exon I.γ干扰素诱导BCL-6基因表达及外显子I中IRE的鉴定
Exp Mol Pathol. 2005 Feb;78(1):25-35. doi: 10.1016/j.yexmp.2004.08.008.
7
Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function.转录抑制因子BCL-6在缺乏p53功能的情况下使生发中心样B细胞永生化。
Oncogene. 2004 Jan 22;23(3):839-44. doi: 10.1038/sj.onc.1207065.
8
Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.LAZ3(BCL6)原癌基因的表达增加伴随着小鼠骨骼肌生成。
Differentiation. 1998 Nov;64(1):33-44. doi: 10.1046/j.1432-0436.1998.6410033.x.
9
Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.缺乏Ets蛋白Spi-B的小鼠中B细胞受体介导的反应存在缺陷。
EMBO J. 1997 Dec 1;16(23):7118-29. doi: 10.1093/emboj/16.23.7118.
10
Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells.Bcl-6在记忆性CD8+ T细胞生成与维持中的作用。
Nat Immunol. 2002 Jun;3(6):558-63. doi: 10.1038/ni802. Epub 2002 May 20.

引用本文的文献

1
Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation.强制表达MYC在浆细胞分化过程中引导一种独特的转录状态。
Life Sci Alliance. 2025 Jul 28;8(10). doi: 10.26508/lsa.202402814. Print 2025 Oct.
2
Epstein-Barr virus-infected tonsillar marginal zone B cells as a precursor for immunosuppression-related B-cell lymphoma.爱泼斯坦-巴尔病毒感染的扁桃体边缘区B细胞作为免疫抑制相关B细胞淋巴瘤的前体。
J Virol. 2025 Jul 8:e0105124. doi: 10.1128/jvi.01051-24.
3
Autophagy is an upstream mediator of chromatin dynamics in normal and autoimmune germinal center B cells.
自噬是正常和自身免疫生发中心B细胞中染色质动态变化的上游调节因子。
J Clin Invest. 2025 May 15;135(13). doi: 10.1172/JCI178920. eCollection 2025 Jul 1.
4
Flow Cytometry-Based Rapid Assay for Antigen Specific Antibody Relative Affinity in SRBC-Immunized Mouse Models.基于流式细胞术的SRBC免疫小鼠模型中抗原特异性抗体相对亲和力的快速检测方法
Int J Mol Sci. 2025 Apr 12;26(8):3664. doi: 10.3390/ijms26083664.
5
Resveratrol as a BCL6 natural inhibitor suppresses germinal center derived Non-Hodgkin lymphoma cells growth.白藜芦醇作为一种BCL6天然抑制剂可抑制生发中心来源的非霍奇金淋巴瘤细胞生长。
J Nat Med. 2025 Mar;79(2):399-411. doi: 10.1007/s11418-024-01873-4. Epub 2025 Jan 15.
6
IL-21 shapes the B cell response in a context-dependent manner.白细胞介素-21以一种依赖于环境的方式塑造B细胞反应。
Cell Rep. 2025 Jan 28;44(1):115190. doi: 10.1016/j.celrep.2024.115190. Epub 2025 Jan 9.
7
B Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond.B 细胞淋巴瘤因子 6(BCL6):免疫调节的保守调控因子及其它功能。
Int J Mol Sci. 2024 Oct 11;25(20):10968. doi: 10.3390/ijms252010968.
8
Relocalizing transcriptional kinases to activate apoptosis.将转录激酶重定位以激活细胞凋亡。
Science. 2024 Oct 4;386(6717):eadl5361. doi: 10.1126/science.adl5361.
9
Specific Mutation Predict Relapse/Refractory Diffuse Large B-Cell Lymphoma.特定突变可预测复发/难治性弥漫性大B细胞淋巴瘤。
J Blood Med. 2024 Sep 10;15:407-419. doi: 10.2147/JBM.S471639. eCollection 2024.
10
MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis.MEF2B C 端突变增强转录活性和稳定性,从而驱动 B 细胞淋巴瘤的发生。
Nat Commun. 2024 Aug 21;15(1):7195. doi: 10.1038/s41467-024-51644-8.